Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
Sasaki
Makoto
M
Sugimoto
Koichi
K
Isobe
Yasushi
Y
Oshimi
Kazuo
K
D000971:Antineoplastic Combined Chemotherapy Protocols; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D010087:Oxides / Q000627:therapeutic use*; D012074:Remission Induction; D016879:Salvage Therapy; D014212:Tretinoin / Q000627:therapeutic use*
D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide